Related Experiment Video

Updated: Jul 8, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.8K

Tiam1 methylation by NSD2 promotes Rac1 signaling activation and colon cancer metastasis

Da Song1, Fuqing Hu1, Changsheng Huang1

  • 1Department of Gastrointestinal Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China.

Proceedings of the National Academy of Sciences of the United States of America
|December 19, 2023
PubMed

Insights

NSD2 overexpression enhances cancer metastasis by activating Rac1 signaling through Tiam1 methylation. Targeting this interaction with inhibitory peptides offers a novel strategy for metastasis inhibition.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Cancer metastasis is a primary driver of mortality and treatment failure.
  • Targeting the mechanisms of metastatic seeding and colonization is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify novel molecular targets for inhibiting cancer metastasis.
  • To elucidate the role of NSD2 in promoting tumor metastasis.

Main Methods:

  • Investigated NSD2 expression in metastatic tumors.
  • Assessed the impact of NSD2 on metastasis in vitro and in vivo.
  • Examined the interaction between NSD2, Tiam1, and Rac1 signaling.
  • Developed and tested an inhibitory peptide targeting the NSD2-Tiam1 interaction.

Main Results:

  • NSD2 was found to be overexpressed in metastatic tumors and enhances metastasis.
  • NSD2 activates Rac1 signaling by methylating Tiam1 at K724, promoting tumor spread.
  • Tiam1 K724 methylation serves as a prognostic factor and potential therapeutic target.
  • An inhibitory peptide effectively blocked NSD2-Tiam1 interaction and inhibited metastasis.

Conclusions:

  • NSD2-mediated Tiam1 methylation is a key driver of Rac1 signaling and cancer metastasis.
  • Targeting the NSD2-Tiam1 interaction presents a promising therapeutic strategy for combating metastasis.
Keywords:
NSD2Rac1 signalingTiam1 methylationcancer metastasis

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.0K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K